Literature DB >> 15357037

Pulmonary involvement in Henoch-Schönlein purpura.

Hassan F Nadrous1, Aimee C Yu, Ulrich Specks, Jay H Ryu.   

Abstract

OBJECTIVE: To describe pulmonary involvement in Henoch-Schönlein purpura (HSP). PATIENTS AND METHODS: We retrospectively reviewed the medical records of patients with HSP who were seen at the Mayo Clinic in Rochester, Minn, during a 6-year period (January 1, 1997, to December 31, 2002). Patients with HSP and pulmonary involvement were identified through a review of clinical records, radiological studies, pulmonary function data, and lung biopsy findings.
RESULTS: We identified 124 patients with HSP during the study period; 72 (58.1%) were males. The median age was 15 years (range, 8 months to 81 years). Among the 124 patients with HSP, 3 (2.4%), all adults, had pulmonary involvement. Of these 3 patients, aged 20, 67, and 76 years, 2 were women. Pulmonary manifestations consisted of diffuse alveolar hemorrhage (DAH) (2 patients) and usual interstitial pneumonia that improved with corticosteroid therapy (1 patient).
CONCLUSIONS: Pulmonary involvement in HSP is rare. It occurs more often in adults and commonly manifests as DAH and occasionally as usual interstitial pneumonia or interstitial fibrosis. Our cases and previously reported cases suggest that DAH is the most common manifestation of pulmonary involvement in HSP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15357037     DOI: 10.4065/79.9.1151

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  23 in total

1.  Henoch-Schönlein purpura: a clinical case with dramatic presentation.

Authors:  João Bento; Adriana Magalhães; Conceição Souto Moura; Venceslau Hespanhol
Journal:  BMJ Case Rep       Date:  2010-09-09

Review 2.  Multisystemic manifestations of IgA vasculitis.

Authors:  Lina Du; Panpan Wang; Chang Liu; Shaojing Li; Shuang Yue; Yan Yang
Journal:  Clin Rheumatol       Date:  2020-06-16       Impact factor: 2.980

3.  Pulmonary involvement in Henoch-Schonlein purpura.

Authors:  A Soloukides; D-A Moutzouris; G Metaxatos; V Hadjiconstantinou
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

4.  The clinical implications of adult-onset henoch-schonelin purpura.

Authors:  Warit Jithpratuck; Yasmin Elshenawy; Hana Saleh; George Youngberg; David S Chi; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2011-05-27

Review 5.  Pulmonary vasculitis.

Authors:  Ana Casal; Juan Díaz-Garel; Tara Pereiro; María E Toubes; Jorge Ricoy; Luis Valdés
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

6.  Pulmonary renal syndrome in an adult patient with Henoch-Shönlein purpura.

Authors:  Th Eleftheriadis; V Liakopoulos; M Boulbou; F Karasavvidou; E Atmatzidis; S Dovas; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2006-10       Impact factor: 0.471

Review 7.  Clinical practice: Diagnosis and management of Henoch-Schönlein purpura.

Authors:  Hugh J McCarthy; E Jane Tizard
Journal:  Eur J Pediatr       Date:  2009-12-12       Impact factor: 3.183

8.  No impairment of pulmonary function in children with Henoch-Schonlein purpura after 4-year follow-up.

Authors:  Izabela Grabska-Kobylecka; Dariusz Nowak; Anna Wlodarczyk; Piotr Bialasiewicz
Journal:  Clin Rheumatol       Date:  2016-07-27       Impact factor: 2.980

Review 9.  IgA Vasculitis in Adults: a Rare yet Challenging Disease.

Authors:  Kinanah Yaseen; Leal C Herlitz; Alexandra Villa-Forte
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

10.  An adult patient with Kabuki syndrome presenting with Henoch-Schönlein purpura complicated with pulmonary hemorrhage.

Authors:  Jun Oto; Akiko Mano; Emiko Nakataki; Harutaka Yamaguchi; Daisuke Inui; Hideaki Imanaka; Masaji Nishimura
Journal:  J Anesth       Date:  2008-11-15       Impact factor: 2.078

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.